OUR COMPANY
Infusion Scientific is a new innovation leader in transdermal sciences. We are designing technologies that serve fast growing markets, such as the intravenous solution market which is growing 7.7% annually*.
Our products cover 3 market segments:
- Novel needle technologies (example: microneedles utilizing SĀSO™ technology, anti-seed biopsy needles, etc)
- New-market-oriented infusion pump technologies (SmartSaline™, STEADI™ pumps, highly accurate flow-rate valves, etc)
- Dermatology innovations (SkinSoak™, and Infusif™) taking advantage of new materials and redox-maximizing skin-nutrition delivery methods.
OUR VISION
Infusion Scientific occupies a unique space within the medical infusion market, improving high-selectivity therapies which have different needs and properties compared to conventional pharmaceuticals. Additionally, this out-of-the-box approach has also resulted in products, like our microneedle arrays, that also have applications in the conventional pharmaceutical market and the fast growing consumer-med market. We look forward to delivering as much value to our investors and partners as our technology delivers wellness and life saving therapies based on our innovations.
OUR COMPANY
Infusion Scientific is a new innovation leader in transdermal sciences. We are designing technologies that serve fast growing markets, such as the intravenous solution market which is growing 7.7% annually*.
Our products cover 3 market segments:
- Novel needle technologies (example: microneedles utilizing SĀSO™ technology, anti-seed biopsy needles, etc)
- New-market-oriented infusion pump technologies (SmartSaline™, STEADI™ pumps, highly accurate flow-rate valves, etc)
- Dermatology innovations (SkinSoak™, and Infusif™) taking advantage of new materials and redox-maximizing skin-nutrition delivery methods.
OUR VISION
Infusion Scientific occupies a unique space within the medical infusion market, improving high-selectivity therapies which have different needs and properties compared to conventional pharmaceuticals. Additionally, this out-of-the-box approach has also resulted in products, like our microneedle arrays, that also have applications in the conventional pharmaceutical market and the fast growing consumer-med market. We look forward to delivering as much value to our investors and partners as our technology delivers wellness and life saving therapies based on our innovations.